Ads
related to: Severe Asthma Treatments- Pay As Little As $0
Get Information About A Savings
Program & Learn If You Are Eligible
- What Is E-Asthma?
Visit The Official Patient Site To
Learn About Your Asthma Condition.
- Sign Up For Email Updates
Receive Personalized Resources For
Your Asthma Journey, Sign Up.
- Patient Support Tools
Access Different Asthma Resources
That Are Available To You.
- Find An Asthma Specialist
Take Control Of Your Asthma
Condition & Find A Doctor Near You.
- Access The FAQ Page
Get Your Asthma & Treatment
Questions Answered At The Site.
- Pay As Little As $0
Search results
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks· 1 day agoGSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 2 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 2 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a ...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 2 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
WFRV 5 Green Bay· 4 days agoThe primary results showed that treatment with Tezspire led to a 17% numerical reduction in the annual rate of moderate or severe COPD exacerbations compared ...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 2 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Medical Xpress· 2 days agoIn the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...
GSK finds success in severe asthma drug trials
Becker’s Hospital Review· 2 days agoThe drug candidate, depemokimab, was measured in severe asthma patients with Type 2 inflammation characterized by blood eosinophil count, GSK said in a ...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via Yahoo News· 2 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
SMART Inhalers: The Overlooked Solution in Asthma Management
SciTechDaily· 2 days agoAccording to research presented at the ATS 2024 International Conference, only 14.5 percent of adult...
Ads
related to: Severe Asthma Treatments
